Joint Management Committee. 9 (a) Composition of the JMC........................................................................9 (b) JMC Meetings..................................................................................9 (c) JMC Responsibilities.........................................................................10 (d) Deadlock.....................................................................................10 2.6 SPL'S DEVELOPMENT OBLIGATIONS................................................................10 (a) SPL Diligence................................................................................10 (b) Opportunity to Cure..........................................................................10 (c) Research and Development Activities..........................................................11 (d) Licensed Product Registrations; Pricing Reimbursement Approvals..............................11 (e) Data.........................................................................................11 (f)
Appears in 3 contracts
Samples: Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc)
Joint Management Committee. 9 (a) Composition of the JMC........................................................................9 (b) JMC Meetings..................................................................................9 .................................................................................10 (c) JMC Responsibilities.........................................................................10 (d) Deadlock.....................................................................................10 2.6 SPLSCHERING'S DEVELOPMENT OBLIGATIONS...........................................................................................................................10 (a) SPL Schering Diligence...........................................................................................................................................................10 (b) Opportunity to Cure..........................................................................10 11 (c) Research and Development Activities..........................................................11 (d) Licensed Product Registrations; Pricing Reimbursement Approvals..............................11 (e) Data.........................................................................................11 12 (f)
Appears in 3 contracts
Samples: Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc), Exclusive License Agreement (Atherogenics Inc)